ClinicalTrials.govpublic full text
Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study
cd40l-hyperigm syndrome, base editing, gene editing, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 878235
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.